Saxagliptin Intermediate E |
|
Synonyms: Boc-3,5-dihydroxy-1-adamantyl-L-glycine (S)-2-((tert-Butoxycarbonyl)amino)-2-((1r,3R,5S,7S)-3,5-dihydroxyadamantan-1-yl)acetic Acid; (aS)-a-[[(1,1-Dimethylethoxy)carbonyl]amino]-3,5-dihydroxytricyclo[3.3.1.13,7]decane-1-acetic Acid | |
Cat. No.: S12049 | CAS No.: 681282-72-4 |
MDL.: | Formula: C17H27NO6 |
F.W.341.4 | Purity: 99% |
Storage: | |
  |

Catalog Number: | S12049 | CAS No.: | 681282-72-4 | |
MDL: | Formula: | C17H27NO6 | ||
F.W.: | 341.4 | Purity: | 99% | |
Package: | Unit: | mg | ||
Appearance: | M.P.: | |||
B.P.: | Density: | |||
Optical Rotation: | Refractive Index: | |||
Solubility: | Stability: | |||
Storage: | Category: | Reference Standard | ||
Reference: | Augeri, D.J., et. al.: J. Med. Chem., 48, 5025 (2005); Feng, J., et al.: J. Med. Chem., 50, 2297 (2007); Rosenstock, J., et al.: Diabetes Obes. Metab., 10, 376 (2008); Thomas, L., et al.: J. Pharmacol. Exp. Ther., 325, 175 (2008) | |||
Application: | Boc-3,5-dihydroxy-1-adamantyl-L-glycine is a reactant in the synthesis of of Saxagliptin, a potent and selective reversible inhibitor of dipeptidyl peptidase-4, which is being developed for the treatment of type 2 diabetes. It is absorbed rapidly after oral administration and has a pharmacokinetic profile compatible with once daily dosing. | |||
Category: | Amino Acids & Derivatives, Chiral Reagents |